nifurtimox
Selected indexed studies
- Nifurtimox. (Am J Health Syst Pharm, 2020) [PMID:33289026]
- Chagas Disease. (Ann Intern Med, 2023) [PMID:36780647]
- Update on nifurtimox for treatment of Chagas disease. (Drugs Today (Barc), 2021) [PMID:33851689]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Nifurtimox. (2020) pubmed
- Chagas Disease. (2023) pubmed
- Update on nifurtimox for treatment of Chagas disease. (2021) pubmed
- Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox. (2023) pubmed
- Nifurtimox (Lampit) for Chagas disease. (2024) pubmed
- Chagas Disease: Epidemiology, Diagnosis, and Treatment. (2024) pubmed
- Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox. (2025) pubmed
- Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria. (2017) pubmed
- [Efficacy of nifurtimox for the treatment of chronic Chagas disease]. (2012) pubmed
- Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding. (2022) pubmed